Skip to main content

Registration Open for Countdown to 2025: Progress on Ending Alzheimer’s Disease

443 Conference Ask the Doc cropped for web

Register Now . . . for the 24th Annual Southern California Alzheimer’s Disease Conference, Countdown to 2025: Progress on Ending Alzheimer’s Disease, to be held on Friday, September 20, 2013 at the Hilton Orange County/Costa Mesa.

America’s first National Plan to Address Alzheimer’s Disease sets forth the goal of effectively preventing and treating this progressive neurodegenerative disorder by 2025. In the U.S., over 5.4 million people are living with Alzheimer’s disease and a new case is diagnosed every 68 seconds. Unless significant progress is made, at least 13.8 million Americans will have Alzheimer’s disease by 2050, with a new case diagnosed every 33 seconds.

Register Now Button

Hosted by the UCI Institute for Memory Impairments and Neurological Disorders (UCI MIND) and the Alzheimer’s Association, Orange County Chapter, this conference convenes nationally and internationally recognized experts to address the progress our nation is making in the fight against Alzheimer’s disease.  (See conference schedule below.)

Physicians, healthcare professionals, and families in attendance will learn new ways scientists and clinicians are approaching the diagnosis, treatment, and prevention of Alzheimer’s disease.  From new nomenclature for cognitive disorders introduced in the recently released DSM-V and the application of amyloid imaging biomarkers to pioneering research investigating stem cell therapy and the first Alzheimer’s prevention trial, this conference presents the advances critical to achieving our national goal.

Therapeutic approaches being highlighted during the conference include (1) reducing production, limiting aggregation and/or increasing removal of amyloid, (2) controlling inflammation, and (3) stem cell therapies.  Scientists believe application of new therapies pre-clinically is essential to effectively preventing Alzheimer’s disease.  Being reported on at this conference, the first Alzheimer’s prevention trial is testing the ability of three drugs to halt emergence of the disease in healthy individuals with genetic mutations that place them at high risk for developing early-onset Alzheimer’s.

While pharmacological approaches to prevention are under

study, lifestyle strategies currently represent the most effective way to reduce risk for developing Alzheimer’s disease.  Physicians, allied healthcare professionals and families will be empowered to promote and adopt lifestyle strategies to maintain brain health based on The 90+ Study.   Finally, attendees will have to opportunity to learn about the variety of community resources available to help manage the care of a loved one with Alzheimer’s disease or a related dementia.

Continuing medical education credits will be available for physicians (CME) and a variety of other health care professionals, including social workers (BBS), nurses (BRN), nursing home (NHAP) and residential care facility (RCFE) administrators, and attorneys (MCLE).

Time Activity
7:00 – 8:00 am Registration, Breakfast, Exhibits
8 – 8:15 am Welcome and Opening – Year in Review
Frank LaFerla, Ph.D. – UCI MIND
Jim McAleer – Alzheimer’s Association, Orange County Chapter
8:15 – 9:00 am National Plan to Address Alzheimer’s Disease: What’s Next?
Ron Petersen, M.D., Ph.D. – Mayo Clinic
9 – 9:45 am DIAN: Understanding Alzheimer’s Disease in Persons with
Causative Genetic Mutations
John Morris, M.D. – Washington University
9:45 – 10:15 am Break
10:15 – 11:00 am Inflammation as a Therapeutic Target in Alzheimer’s Disease
Andrea Tenner, Ph.D. – University of California, Irvine
11:00 – 11:45 am Preventing Alzheimer’s Disease: What We’ve Learned from the Oldest Old
Claudia Kawas, M.D. – University of California, Irvine
11:45 am – 1:15 pm Lunch
Clinical Track Research Track
1:15 – 2:00 pm DSM-V: Renaming Dementia
Ron Petersen, M.D., Ph.D. –
Mayo Clinic
New Hope: Stem Cell Therapy in Alzheimer’s Disease
Mathew Blurton-Jones, Ph.D. –
University of California, Irvine
2:00 – 2:45 pm Best Practices in Diagnosis and Treatment of Alzheimer’s Disease
Bruce Miller, M.D. –
University of California, San Francisco
The Role of Amyloid in the Development and Treatment of Alzheimer’s Disease
Charles Glabe, Ph.D. –
University of California, Irvine
2:45 – 3:15 pm Break Break
3:15 – 4:00 pm Neuroimaging: An Early Diagnostic Marker
Adam Fleisher, M.D. , M.A.S.
Banner Alzheimer’s Institute
Phoenix, AZ
Progress in Immunotherapy for Treating Alzheimer’s Disease
David Cribbs, Ph.D. –
University of California, Irvine
4:00 – 4:45 pm Ask the Doc Forum – All Speakers
4:45 – 5:00 pm Closing


To register, click here.  For more information or questions, contact Marcelo Soares, Education Coordinator, at (949) 824-9896 or